Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis. (Record no. 10439654)

MARC details
000 -LEADER
fixed length control field 01583 a2200433 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513192244.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199910s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0364-5134
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1002/1531-8249(199909)46:3<296::aid-ana4>3.0.co;2-#
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Coles, A J
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19991020
245 00 - TITLE STATEMENT
Title Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Annals of neurology
Date of publication, distribution, etc. Sep 1999
300 ## - PHYSICAL DESCRIPTION
Extent 296-304 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Alemtuzumab
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Humanized
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Neoplasm
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Enzyme-Linked Immunosorbent Assay
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Inflammation
General subdivision pathology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Magnetic Resonance Imaging
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Multiple Sclerosis
General subdivision pathology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Time Factors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tumor Necrosis Factor-alpha
General subdivision analysis
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wing, M G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Molyneux, P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Paolillo, A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Davie, C M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hale, G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Miller, D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Waldmann, H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Compston, A
773 0# - HOST ITEM ENTRY
Title Annals of neurology
Related parts vol. 46
-- no. 3
-- p. 296-304
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1002/1531-8249(199909)46:3<296::aid-ana4>3.0.co;2-#">https://doi.org/10.1002/1531-8249(199909)46:3<296::aid-ana4>3.0.co;2-#</a>
Public note Available from publisher's website

No items available.